[A new treatment of renal disease in AA amyloidosis...and not only that?].
Pani
Antonello
A
D000686:Amyloidosis / Q000150:complications / Q000188:drug therapy*; D004311:Double-Blind Method; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000517:prevention & control; D015337:Multicenter Studies as Topic / Q000706:statistics & numerical data; D011407:Propane / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D000685:Serum Amyloid A Protein / Q000187:drug effects; D013451:Sulfonic Acids / Q000494:pharmacology / Q000627:therapeutic use*
D000685:Serum Amyloid A Protein; D013451:Sulfonic Acids; C520274:eprodisate; D011407:Propane